跳至主要内容
临床试验/DRKS00031566
DRKS00031566招募中不适用

Measurement of the concentrations of lithium, sodium, potassium and creatinine in the saliva of patients with treatment-resistant depression.

Medizinische Hochschule Brandenburg0 个研究点目标入组 40 人开始时间: 2023年3月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Diagnosis of Unipolar Depression or Bipolar Disorder (I and II).
  • -Existing or planned lithium therapy in inpatient and outpatient treatment
  • -Existing capacity to give consent
  • -Existence of written informed consent

排除标准

  • -Diagnosis of antisocial or other severe personality disorder.
  • -Schizophrenia
  • -Severe cognitive impairment e.g. dementia or severe intelligence impairment
  • -Withdrawal of informed consent
  • -Existing renal insufficiency stage 3 and above (GFR 30-59), severe cardiac or circulatory disease
  • -Institutionalization by court or official order (according to AMG § 40 (1) 4).

研究者

发起方
Medizinische Hochschule Brandenburg

相似试验